Abstract Submission Deadline: December 15, 2025 - Don’t Miss Out – Early Bird Registration Deadline: December 16, 2025 - Submit your Abstract and Secure your Spot Today!

September 14-15, 2026
London, UK

3rd European Hematology and Blood Disorders Congress

Theme : Pioneering Discoveries in Hematology and Blood Disorder Research

About Hematology Congress

Welcome to the 3rd European Hematology and Blood Disorders Congress, scheduled for September 14-15, 2026, in London, UK. This prestigious congress bring together hematologists, oncologists, researchers, clinicians, and healthcare professionals from around the globe to delve into the latest advancements in hematology and blood disorders.

Attendees can expect a comprehensive program featuring keynote presentations, interactive workshops, poster sessions, and panel discussion covering hematologic disorders, transfusion medicine, stem cell transplantation, immunotherapy, and precision medicine in hematology.

The congress serves as a vital platform for knowledge exchange, networking, and collaboration among expert and stakeholders in the field. Participants will have the opportunity to explore innovative therapies, discuss emerging research findings, and address challenges in hematology practice and patient care.

Join us in London to contribute to advancements in hematology and blood disorders, forging connections that drive progress and improve outcomes for patients worldwide.

Sessions

Hematology and Blood Disorders
Blood Disorders Types, Diagnosis and Treatment
Hematology-Oncology
Neuro-Hematology
Disseminated intravascular coagulation (DIC)
Hemoglobinopathies
Hematology Nursing
Vascular Bleeding Disorders
Hemoglobin and Iron Metabolism
Advanced Treatment and Research in Hematology
Biomarkers in Hematologic Diseases
Emerging Technologies in Hematology
Epidemiology and Public Health in Hematology
Immunohematology
Leukemia and Blood Cancers
Hemoglobin and Iron Metabolism
Bone Marrow & Cord Blood Transplantation
Acute and Chronic Lymphocytic Leukemia
Hemostasis and Thrombosis
Anemia & Clinical Hematology
Pediatric Hematology
Myelodysplastic and Myeloproliferative Disorders
Hematologic Cancer
Transfusion Medicine
Submit Your Abstract

Track Your Abstract

Important Dates

Abstract Submission: Dec 15, 2025

Early Bird Registration: Dec 16, 2025

Mid Term Registration: July 31, 2026

Final/Onsite Registration: Sep 14, 2026

Why Attend Conference
  • Gain insights into the latest research, treatments, and innovations in hematology and blood disorders.
  • Connect with leading hematologists, oncologists, researchers, and healthcare professionals from around the world.
  • Stay updated with evolving guidelines, clinical trials, and best practices in the field of hematology.
  • Learn about cutting-edge technologies & therapies shaping the future of hematology & blood disorder treatments.
  • Gain practical insights and strategies to improve patient outcomes and quality of care in hematology.
Learning

Gain insights and skills through presentations, workshops, and discussions on cutting-edge research and trends.

Networking

Connect with peers, experts, and collaborators to expand your professional network.

Perspectives

Explore diverse viewpoints and cultural insights, discovering new approaches and trends in your field.

Past Conference Report

Hematology Congress 2025

C2P Forum is pleased to announce the successful completion of the 2nd European Hematology and Blood Disorders Congress, held on November 03-04, 2025, in Prague, Czech Republic.

The conference, themed “Advancing Frontiers in Hematology and Blood Research” concluded with great success.

We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Hematology and Blood Disorders.

The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, and video presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:

  • Paola Dal Cin, Brigham and Women’s Hospital & Harvard Medical School, USA
  • Genia Burchall, Central Queensland University, Australia
  • Avigdor Scherz, The Weizmann Institute of Science, Israel
  • Giacomina Brunetti, University of Bari Aldo Moro, Italy
  • Martyna Pytlarz, Technical University of Denmark, Denmark
  • Ch’ng You Qun, University Hospitals of Leicester NHS Trust, UK
  • Laura Cerchia, Institute of Endotypes in Oncology, Metabolism and Immunology “G.Salvatore”- National Research Council (IEOMI-CNR), Italy
  • Folinas Konstantinos, 251 Airforce General Hospital, Greece
  • Ella Fernandes, King's College London NHS Trust, UK
  • Monica Fedele, Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”- National Research Council (IEOMI-CNR), Italy
  • Shivani Golem, University of Kansas Medical Center, USA
  • Swapnil Surpur, Wright Center for Graduate Medical Education, USA
  • Siqi Hua, Shanghai Jiao Tong University School of Medicine, China
  • Ema Ruszova, University Hospital Bulovka, Czech Republic
  • Silvia Scaglione, National Research Council (CNR), Italy
  • Amal Assef Nasser, Phoenicia Medical Center (PMC), Lebanon
  • Daniel Tippner, Martin Luther University Halle-Wittenberg, Germany
  • Mónica G Mendoza-Rodríguez, Universidad Nacional Autónoma de México, México
  • Mike Alexander Celis Rodríguez, Universidad Industrial de Santander, Colombia
  • Morsal Sabihi, University Medical Center Hamburg-Eppendorf, Germany
  • Amira Mahmoud Ali Abdallah, Sheikh Shakhbout Medical City, UAE
  • Ferhat Bostanci, Istanbul Sabahattin Zaim University & Yıldız Technical University, Turkey
  • José Carlos Jaime-Pérez, Universidad Autónoma de Nuevo León, México
  • Andrada Nemesis Crișan, Galaxy Medical Center, Romania
  • Roxana Elena Sicoe, Galaxy Medical Center, Romania
  • Rana Ajami, Ziv Medical Center, Israel
  • Bufan Zhang, Tianjin Medical University General Hospital, China
  • Elena Bukovetzky, Ziv Medical Center, Israel
  • Mona Nassar, Ziv Medical Center, Israel
  • Elena-Mihaela Vrabie, Fundeni Clinical Institute & Carol Davila University of Medicine and Pharmacy, Romania
  • Dan Cacsire Castillo-Tong, Medical University of Vienna, Austria

We would like to express our sincere appreciation to our Session Chairs Folinas Konstantinos, 251 Airforce General Hospital, Greece, Paola Dal Cin, Brigham and Women’s Hospital & Harvard Medical School, USA and Avigdor Scherz, The Weizmann Institute of Science, Israel for their valuable contributions and for skillfully guiding the conference sessions.

Building on the success of the Hematology Congress 2025, we are pleased to announce our upcoming event, 3rd European Hematology and Blood Disorders Congress, on September 14-15, 2026 in London, UK.

More info: https://hematology.c2pforum.com/

Huge thanks to all the delegates! Your energy and involvement made this event a big success!

Mark your calendars and set your reminders.

Hope to meet you again in London, UK!!